CY1118173T1 - 5-[(3,3,3-τριφθορο-2-υδροξυ-1-αρυλπροπυλ)αμινο]-1h-κινολιν-2-ονες, μια διεργασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδων παραγοντων - Google Patents
5-[(3,3,3-τριφθορο-2-υδροξυ-1-αρυλπροπυλ)αμινο]-1h-κινολιν-2-ονες, μια διεργασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδων παραγοντωνInfo
- Publication number
- CY1118173T1 CY1118173T1 CY20161100820T CY161100820T CY1118173T1 CY 1118173 T1 CY1118173 T1 CY 1118173T1 CY 20161100820 T CY20161100820 T CY 20161100820T CY 161100820 T CY161100820 T CY 161100820T CY 1118173 T1 CY1118173 T1 CY 1118173T1
- Authority
- CY
- Cyprus
- Prior art keywords
- production
- arylpropyl
- quinolin
- trifluoro
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
- C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
- C07C45/58—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in three-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
- C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Η παρούσα εφεύρεση αφορά ενώσεις του τύπου (I), διεργασίες για την παραγωγή τους και τη χρήση αυτών ως αντι-φλεγμονωδών παραγόντων.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07076019A EP2062880A1 (en) | 2007-11-22 | 2007-11-22 | 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| PCT/EP2008/009440 WO2009065503A1 (en) | 2007-11-22 | 2008-11-08 | 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| EP08852223.0A EP2234979B1 (en) | 2007-11-22 | 2008-11-08 | 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, process for their production and their use as anti-inflammatory agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1118173T1 true CY1118173T1 (el) | 2017-06-28 |
Family
ID=39575536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20161100820T CY1118173T1 (el) | 2007-11-22 | 2016-08-19 | 5-[(3,3,3-τριφθορο-2-υδροξυ-1-αρυλπροπυλ)αμινο]-1h-κινολιν-2-ονες, μια διεργασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδων παραγοντων |
Country Status (40)
| Country | Link |
|---|---|
| US (3) | US8394958B2 (el) |
| EP (2) | EP2062880A1 (el) |
| JP (1) | JP5559058B2 (el) |
| KR (1) | KR101580700B1 (el) |
| CN (2) | CN103396300A (el) |
| AR (1) | AR069400A1 (el) |
| AU (1) | AU2008328307C1 (el) |
| BR (1) | BRPI0819833B1 (el) |
| CA (1) | CA2705410C (el) |
| CL (1) | CL2008003472A1 (el) |
| CO (1) | CO6280419A2 (el) |
| CR (1) | CR11452A (el) |
| CU (1) | CU23889B1 (el) |
| CY (1) | CY1118173T1 (el) |
| DK (1) | DK2234979T3 (el) |
| DO (1) | DOP2010000152A (el) |
| EA (1) | EA017459B1 (el) |
| EC (1) | ECSP10010192A (el) |
| ES (1) | ES2588170T3 (el) |
| HK (1) | HK1144817A1 (el) |
| HN (1) | HN2010001060A (el) |
| HR (1) | HRP20161015T1 (el) |
| HU (1) | HUE028865T2 (el) |
| IL (1) | IL205117A (el) |
| LT (1) | LT2234979T (el) |
| MA (1) | MA31834B1 (el) |
| MX (1) | MX2010005528A (el) |
| MY (1) | MY151017A (el) |
| NZ (1) | NZ585495A (el) |
| PA (1) | PA8804601A1 (el) |
| PE (1) | PE20091066A1 (el) |
| PL (1) | PL2234979T3 (el) |
| PT (1) | PT2234979T (el) |
| RS (1) | RS55012B1 (el) |
| SI (1) | SI2234979T1 (el) |
| TN (1) | TN2010000219A1 (el) |
| TW (1) | TWI520736B (el) |
| UA (1) | UA100251C2 (el) |
| UY (1) | UY31479A1 (el) |
| WO (1) | WO2009065503A1 (el) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1878717A1 (en) | 2006-07-14 | 2008-01-16 | Bayer Schering Pharma Aktiengesellschaft | Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| WO2009151569A2 (en) * | 2008-06-09 | 2009-12-17 | Combinatorx, Incorporated | Beta adrenergic receptor agonists for the treatment of b-cell proliferative disorders |
| US20100016338A1 (en) * | 2008-07-21 | 2010-01-21 | Bayer Schering Pharma Aktiengesellschaft | 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1-arylquinolin-2-ones, a Process for their Production and their Use as Anti-inflammatory Agents |
| JP6061373B2 (ja) * | 2012-07-24 | 2017-01-18 | 国立研究開発法人産業技術総合研究所 | ２−ヒドロキシベンズアルデヒド化合物、これを含有するコラーゲン細胞外分泌阻害剤及び医薬品組成物 |
| JP2018523667A (ja) * | 2015-08-07 | 2018-08-23 | バイエル・ファルマ・アクティエンゲゼルシャフト | ５−アミノ−キノリン−２（１ｈ）−オンおよびその互変異性体形態５−アミノ−キノリン−２−オールを調製する方法 |
| EP3373936A1 (en) | 2015-11-13 | 2018-09-19 | Bayer Pharma Aktiengesellschaft | 4-(4-cyano-2-thioaryl)dihydropyrimidinones for treating chronic wounds |
| WO2017161518A1 (en) | 2016-03-23 | 2017-09-28 | Astrazeneca Ab | New physical form |
| WO2018046681A1 (en) | 2016-09-08 | 2018-03-15 | Bayer Pharma Aktiengesellschaft | Forms of 5-{[(1s,2s)-1-(2-chloro-3-fluoro-4-methoxyphenyl)-3,3,3-trifluoro-2-hydroxy-2-(methoxymethyl)propyl]amino}-7-fluoro-1h-quinolin-2-one |
| WO2018046678A1 (de) | 2016-09-08 | 2018-03-15 | Bayer Aktiengesellschaft | Glukokorticoid-rezeptor-agonisten enthaltende formulierungen |
| WO2018046685A1 (en) | 2016-09-08 | 2018-03-15 | Bayer Aktiengesellschaft | Quinoline derivatives for treatment of inflammatory skin diseases |
| WO2018046684A1 (en) | 2016-09-08 | 2018-03-15 | Bayer Pharma Aktiengesellschaft | Process for the preparation of substituted 5-{[2-(alkoxymethyl)-3,3,3-trifluoro-2-hydroxy-1-phenylpropyl]amino}quinolin-2(1h)-ones |
| KR20210119980A (ko) * | 2019-01-22 | 2021-10-06 | 아크리베스 바이오메디컬 게엠베하 | 손상된 피부 상처를 치료하기 위한 선택적 글루코코르티코이드 수용체 개질제 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1045180A (en) * | 1963-09-20 | 1966-10-12 | Parke Davis & Co | Quinazoline derivatives |
| US4189453A (en) * | 1977-03-10 | 1980-02-19 | Ciba-Geigy Corporation | Processes for the production of sulphur-containing esters of phosphoric acid and phosphorous acid |
| JPH06172321A (ja) | 1992-10-08 | 1994-06-21 | Agro Kanesho Co Ltd | 置換アミノピリミジン誘導体、その製造法及びそれを有効成分とする有害生物駆除剤 |
| UA57002C2 (uk) * | 1995-10-13 | 2003-06-16 | Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі. | Похідне (метилсульфоніл)феніл-2-(5н)-фуранону, фармацевтична композиція та спосіб лікування |
| WO2000010977A1 (en) | 1998-08-21 | 2000-03-02 | The Scripps Research Institute | Catalytic asymmetric aminohydroxylation with amino-substituted heterocycles |
| DE10038639A1 (de) * | 2000-07-28 | 2002-02-21 | Schering Ag | Nichtsteroidale Entzündungshemmer |
| KR100840846B1 (ko) | 2000-12-22 | 2008-06-23 | 스미스클라인비이참피이엘시이 | 5-[4-[2-(ｎ-메틸-ｎ-(2-피리딜)아미노)에톡시]벤질]티아졸리딘-2,4-디온 메실레이트염 |
| AU2003230700A1 (en) * | 2002-03-26 | 2003-10-13 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| CA2531060A1 (en) | 2003-07-01 | 2005-01-13 | Schering Aktiengesellschaft | Heterocyclically-substitued pentanol derivatives, process for their production and their use as anti-inflammatory agents |
| US20050090559A1 (en) * | 2003-07-01 | 2005-04-28 | Markus Berger | Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents |
| US20050009109A1 (en) * | 2003-07-08 | 2005-01-13 | Stanford University | Fluorophore compounds and their use in biological systems |
| DE10347385A1 (de) * | 2003-10-08 | 2005-05-12 | Schering Ag | Umgelagerte Pentanole, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer |
| EP1878717A1 (en) * | 2006-07-14 | 2008-01-16 | Bayer Schering Pharma Aktiengesellschaft | Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| US20100016338A1 (en) * | 2008-07-21 | 2010-01-21 | Bayer Schering Pharma Aktiengesellschaft | 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1-arylquinolin-2-ones, a Process for their Production and their Use as Anti-inflammatory Agents |
-
2007
- 2007-11-22 EP EP07076019A patent/EP2062880A1/en not_active Withdrawn
-
2008
- 2008-11-08 PL PL08852223.0T patent/PL2234979T3/pl unknown
- 2008-11-08 DK DK08852223.0T patent/DK2234979T3/en active
- 2008-11-08 EP EP08852223.0A patent/EP2234979B1/en active Active
- 2008-11-08 EA EA201000814A patent/EA017459B1/ru not_active IP Right Cessation
- 2008-11-08 CA CA2705410A patent/CA2705410C/en not_active Expired - Fee Related
- 2008-11-08 MX MX2010005528A patent/MX2010005528A/es active IP Right Grant
- 2008-11-08 PT PT88522230T patent/PT2234979T/pt unknown
- 2008-11-08 CN CN2013101575656A patent/CN103396300A/zh active Pending
- 2008-11-08 CN CN2008801173301A patent/CN101868448B/zh not_active Expired - Fee Related
- 2008-11-08 UA UAA201007264A patent/UA100251C2/uk unknown
- 2008-11-08 SI SI200831665A patent/SI2234979T1/sl unknown
- 2008-11-08 KR KR1020107011067A patent/KR101580700B1/ko active IP Right Grant
- 2008-11-08 JP JP2010534394A patent/JP5559058B2/ja not_active Expired - Fee Related
- 2008-11-08 LT LTEP08852223.0T patent/LT2234979T/lt unknown
- 2008-11-08 WO PCT/EP2008/009440 patent/WO2009065503A1/en active Application Filing
- 2008-11-08 AU AU2008328307A patent/AU2008328307C1/en not_active Ceased
- 2008-11-08 MY MYPI20101676 patent/MY151017A/en unknown
- 2008-11-08 NZ NZ585495A patent/NZ585495A/en not_active IP Right Cessation
- 2008-11-08 ES ES08852223.0T patent/ES2588170T3/es active Active
- 2008-11-08 HU HUE08852223A patent/HUE028865T2/en unknown
- 2008-11-08 BR BRPI0819833A patent/BRPI0819833B1/pt not_active IP Right Cessation
- 2008-11-08 RS RS20160676A patent/RS55012B1/sr unknown
- 2008-11-19 PE PE2008001948A patent/PE20091066A1/es active IP Right Grant
- 2008-11-20 TW TW097144922A patent/TWI520736B/zh not_active IP Right Cessation
- 2008-11-20 UY UY31479A patent/UY31479A1/es not_active Application Discontinuation
- 2008-11-20 PA PA20088804601A patent/PA8804601A1/es unknown
- 2008-11-21 CL CL2008003472A patent/CL2008003472A1/es unknown
- 2008-11-21 AR ARP080105069A patent/AR069400A1/es active IP Right Grant
- 2008-11-21 US US12/275,392 patent/US8394958B2/en not_active Expired - Fee Related
-
2010
- 2010-04-15 IL IL205117A patent/IL205117A/en active IP Right Grant
- 2010-05-05 MA MA32817A patent/MA31834B1/fr unknown
- 2010-05-20 TN TN2010000219A patent/TN2010000219A1/fr unknown
- 2010-05-21 CR CR11452A patent/CR11452A/es unknown
- 2010-05-21 HN HN2010001060A patent/HN2010001060A/es unknown
- 2010-05-21 DO DO2010000152A patent/DOP2010000152A/es unknown
- 2010-05-21 CO CO10061149A patent/CO6280419A2/es active IP Right Grant
- 2010-05-21 CU CUP2010000099A patent/CU23889B1/es active IP Right Grant
- 2010-05-21 EC EC2010010192A patent/ECSP10010192A/es unknown
- 2010-12-09 HK HK10111461.5A patent/HK1144817A1/xx not_active IP Right Cessation
-
2012
- 2012-09-13 US US13/614,161 patent/US8680117B2/en not_active Ceased
-
2016
- 2016-03-24 US US15/080,187 patent/USRE47047E1/en active Active
- 2016-08-16 HR HRP20161015TT patent/HRP20161015T1/hr unknown
- 2016-08-19 CY CY20161100820T patent/CY1118173T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118173T1 (el) | 5-[(3,3,3-τριφθορο-2-υδροξυ-1-αρυλπροπυλ)αμινο]-1h-κινολιν-2-ονες, μια διεργασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδων παραγοντων | |
| CY1112520T1 (el) | Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες | |
| CY1112495T1 (el) | Κυτταροτοξικοι παραγοντες που περιλαμβανουν νεα παραγωγα τομαϋμυκινης | |
| BRPI0615705A2 (pt) | processo para preparar um composto, e, composto | |
| CY1118630T1 (el) | Στερεες μορφες 3-(6-(1-(2,2-διφθοροβενζο[d][1,3]διοξολ-5-υλο)-κυκλοπροπανοκαρβοξαμ1δο)-3-μεθυλοπυριδιν-3-υλο)-βενζοϊκου οξεος | |
| CY1118658T1 (el) | Συνθεση 18f-ραδιοεπισημασμενων στυρυλοπυριδινων απο τοσυλικες προδρομες ενωσεις και σταθερες φαρμακευτικες συνθεσεις αυτων | |
| CY1112467T1 (el) | Παραγωγα 1-θειο-d-γλυκιτολης | |
| CL2014000270A1 (es) | Compuestos derivados de 3,5-difenil diazoles sustituidos, inhibidores de la agregacion de proteinas. (divisional de la solicitud n° 1369-2010). | |
| RS52823B (en) | NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES | |
| EA201001205A1 (ru) | Соединения, содержащие циклобутоксигруппу | |
| CY1111269T1 (el) | Ρυθμιστες βενζιμιδαζολης του vr1 | |
| CY1110034T1 (el) | Παραγωγα 1,2,4,5-τετραϋδρο-3h-βενζαζεπινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν | |
| CY1105994T1 (el) | Aναδιαταγμενες πεντανολες, μεθοδος για την παραγωγη αυτων και η χρηση αυτων ως αντιφλεγμονωδων | |
| ATE554066T1 (de) | Entzündungshemmende substituierte cyclobutendionverbindungen | |
| UA106880C2 (uk) | Нові гербіциди | |
| CY1111954T1 (el) | Παραγωγα τετραϋδροναφθαλινιου, μεθοδοι για την παραγωγη αυτων και η χρηση αυτων ως αντιφλεγμονωδη | |
| TW200716564A (en) | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
| DE502005008057D1 (de) | Substituierte cyclopenten-verbindungen | |
| EA200801549A1 (ru) | Новые производные фенантридина в качестве антагонистов брадикинина | |
| DE502007003531D1 (de) | Verfahren zum herstellen von alkylaniliden aus halogenbenzolderivaten | |
| ATE517900T1 (de) | Heptarylen-und octarylentetracarbonsäurediimide und deren herstellung | |
| CY1110944T1 (el) | Νεα παραγωγα κυκλοαλκυλιωμενων βενζοθειαδιαζινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν | |
| RS53747B1 (en) | FENANTRENON UNITS, COMPOSITIONS AND METHODS | |
| SE0701694L (sv) | Nya bronkdilaterande a,b-omättade amider | |
| EA200870157A1 (ru) | Производные 2-карбамид-4-фенилтиазола, их получение и их применение в терапии |